On June 14th, Tigermed fell more than 9%, followed by But'one Information Corporation, Wanbang Pharma, Pharmaron, WuXi AppTec, Sunshine Nohow, and others.
A股CRO概念震荡走低 泰格医药跌超9%
The A-share CRO concept is fluctuating and declining, with Tigermed's stock falling more than 9%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.